Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

SE Sattui, JW Liew, ER Graef… - Expert Review of …, 2020 - Taylor & Francis
Introduction Several months into the COVID-19 pandemic, safe and effective treatments
against this global health disaster have yet to be identified. Clinical research trials around …

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients

SGP Funnell, WE Dowling, C Muñoz-Fontela… - Nature …, 2020 - nature.com
There is an urgent need for drugs, therapies and vaccines to be available to protect the
human population against COVID-19. One of the first approaches taken in the COVID-19 …

[HTML][HTML] Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

EA Meyerowitz, AGL Vannier, MGN Friesen… - The FASEB …, 2020 - ncbi.nlm.nih.gov
There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐
19). Early anecdotal reports and limited in vitro data led to the significant uptake of …

The rise and fall of hydroxychloroquine for the treatment and prevention of COVID-19

Z Lee, CR Rayner, JI Forrest… - … American journal of …, 2020 - pmc.ncbi.nlm.nih.gov
The efficacy and safety of hydroxychloroquine (HCQ) for the prevention and treatment of
COVID-19 has received great attention, and most notably, the enthusiasm for HCQ has been …

Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution

B Mégarbane - Clinical Toxicology, 2021 - Taylor & Francis
To the editor, Since December 2019, a pandemic outbreak of emerging coronavirus disease
(COVID-19) due to SARS-CoV-2 is spreading, resulting in exponentially increasing numbers …

Chloroquine and hydroxychloroquine in the management of COVID-19: much kerfuffle but little evidence

M Roustit, R Guilhaumou, M Molimard, MD Drici… - Therapies, 2020 - Elsevier
Chloroquine and hydroxychloroquine are drugs that have shown in vitro activity on the
replication of certain coronaviruses. In the context of the SARS-Cov-2 epidemic, the virus …

Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection

M Infante, C Ricordi, R Alejandro… - Expert review of anti …, 2021 - Taylor & Francis
Introduction Over the last few months, coronavirus disease 2019 (COVID-19) pandemic
caused by the novel coronavirus SARS-CoV-2 has posed a serious threat to public health …

Misguided use of hydroxychloroquine for COVID-19: the infusion of politics into science

MS Saag - Jama, 2020 - jamanetwork.com
PETAL Clinical Trials Network, focused on hospitalized patients with moderate to severe
disease. In this wellconducted, appropriately powered clinical trial, the authors randomized …

[HTML][HTML] Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety

M Takla, K Jeevaratnam - Saudi Pharmaceutical Journal, 2020 - Elsevier
The COVID-19 pandemic has required clinicians to urgently identify new treatment options
or the re-purposing of existing drugs. Of particular interest are chloroquine (CQ) and …

Hydroxychloroquine as prophylaxis for COVID-19: a review

M Monti, B Vertogen, C Masini, C Donati… - Frontiers in …, 2020 - frontiersin.org
The impact of the COVID-19 pandemic worldwide has led to a desperate search for effective
drugs and vaccines. There are still no approved agents for disease prophylaxis. We thus …